Doxorubicin Hydrochloride 00069-1542-20
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 22, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA050629
Need to source Doxorubicin Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Doxorubicin Hydrochloride | 2 mg/mL |
Drug Class
Anthracycline Topoisomerase Inhibitor [EPC]Anthracyclines [CS]Topoisomerase Inhibitors [MoA]
Selected Package
00069-1542-20Selected1 VIAL, MULTI-DOSE in 1 CARTON (0069-1542-20) / 100 mL in 1 VIAL, MULTI-DOSE